10 Year Financial Data of Mednax, Inc. (MD)

92.21 (1y: +44%)

Market Cap	4.62 B	P/E(ttm)	18.60
Enterprise Value	4.77 B	P/B	2.30

MD- NYSE (USA)
Mednax, Inc.

Currently 5/5

Business Predictability Rank: 5-Star
Back Testing Results:
Average gain of all 5-Star stocks: 12.1% per year.
% of Stocks that are in still loss if held for 10yrs: 3%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$92.21

3 Severe Warning Signs 3 Medium Warning Signs 1 Good Sign

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	14.7	11.8	14.4
EBITDA Growth (%)	13.3	11.2	10.7
Free Cash Flow Growth (%)	11.6	12.4	32.9
Book Value Growth (%)	15.7	18.7	14.8

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	11.21	12.52	14.49	16.57	18.39	22.65	27.72	29.46	32.55	36.56	37.97	8.56	9.07	9.50	9.42	9.98
EBITDA per Share	2.96	3.35	3.29	4.21	4.64	5.41	6.58	7.04	7.80	8.46	8.70	1.75	2.17	2.31	2.22	2.00
Free Cashflow per Share	2.09	2.36	3.23	3.33	3.61	3.51	4.87	4.80	4.91	6.26	6.51	-0.71	2.29	2.64	2.03	-0.45
Earnings per Share ($)	1.72	1.99	1.86	2.52	2.86	3.59	3.78	4.26	4.47	4.85	4.96	0.98	1.22	1.32	1.32	1.10
Book Value per Share	11.64	11.54	14.45	17.53	19.22	20.46	25.61	30.43	35.47	40.96	41.79	36.39	37.75	39.13	40.66	41.79
Month End Stock Price	27.55	32.03	44.29	48.90	68.15	31.70	60.11	67.29	72.01	79.52	89.63	74.37	68.54	74.45	79.52	89.63
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	14.70	17.20	12.90	14.40	14.90	17.50	14.80	14.00	12.60	11.80	10.40	10.80	12.80	13.60	12.80	10.40
Return on Assets %	11.80	12.50	9.90	11.00	11.00	11.30	10.40	9.90	9.60	8.80	8.00	8.40	10.40	10.40	9.60	8.00
Return on Capital - Joel Greenblatt %	559	497	3,310	--	2,212	--	--	--	294	318	163	143	213	296	336	163
Debt to Equity	0.00	0.10	0.00	0.00	0.00	0.15	0.04	0.10	0.02	0.07	0.09	0.05	--	0.03	0.07	0.09

Gross Margin %	96.60	96.10	96.00	38.70	38.20	35.60	35.10	34.90	34.70	33.80	30.60	31.60	34.60	34.60	34.20	30.60
Operating Margin %	24.80	25.20	21.30	24.20	24.10	22.70	22.40	22.30	22.40	21.40	18.20	18.80	22.20	22.70	21.90	18.20
Net Margin %	15.30	15.90	12.80	15.20	15.60	15.80	13.60	14.50	13.70	13.30	11.00	11.40	13.50	13.90	14.00	11.00

Days Sales Outstanding	62.40	63.50	58.80	56.00	57.90	55.50	48.20	47.20	52.90	49.80	47.80	51.00	48.80	48.20	47.90	47.80

Debt to Revenue	0.00	0.09	0.00	0.00	0.00	0.13	0.04	0.11	0.02	0.08	0.37	0.20	0.00	0.10	0.31	0.37
COGS to Revenue	0.03	0.04	0.04	0.61	0.62	0.64	0.65	0.65	0.65	0.66	0.69	0.68	0.65	0.65	0.66	0.69
Interest Exp. to Revenue %	-0.25	-0.21	-0.33	-0.13	-0.08	-0.34	-0.23	-0.23	-0.23	-0.07	-0.16	-0.13	-0.19	-0.04	-0.11	-0.16

Asset Turnover	0.77	0.79	0.77	0.72	0.70	0.71	0.76	0.69	0.70	0.66	0.18	0.18	0.19	0.19	0.17	0.18
Buyback Ratio	-33.10	-34.30	-57.80	-24.00	-19.20	-6.90	-10.20	-11.10	-14.40	-12.00	-9.40	-19.20	-7.50	-7.60	-15.10	-9.40
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	551	620	694	819	918	1,068	1,288	1,402	1,588	1,817	1,897	423	450	473	471	503
Cost of Goods Sold	18.59	24.25	27.68	502	567	688	836	912	1,037	1,203	1,262	289	294	310	310	349
Gross Profit	533	595	666	317	350	380	453	489	551	614	635	133	156	163	161	154

Selling, General, &Admin. Expense	387	430	508	109	120	125	147	154	170	194	200	46.87	48.20	48.20	50.27	53.32
Earnings Before DDA	145	166	158	208	231	255	306	335	381	420	435	86.50	107	115	111	101

Depreciation, Depletion and Amortization	8.41	9.35	9.92	9.47	10.56	13.21	16.72	21.95	25.29	30.82	32.85	7.11	7.69	7.93	8.09	9.14

Operating Income	137	156	148	198	221	242	289	313	355	390	402	79.39	99.74	107	103	91.55
Interest Income/Expense	-1.37	-1.30	-2.26	-1.03	-0.75	-3.59	-2.91	-3.19	-3.64	-1.35	-2.38	-0.55	-0.85	-0.20	-0.54	-0.79
Net Income	84.33	98.28	89.04	124	143	169	176	203	218	241	248	48.35	60.54	65.91	66.10	55.37

Earnings per Share ($)	1.72	1.99	1.86	2.52	2.86	3.59	3.78	4.26	4.47	4.85	4.96	0.98	1.22	1.32	1.32	1.10
Total Shares Outstanding	49.15	49.49	47.86	49.39	49.90	47.16	46.47	47.57	48.80	49.69	50.39	49.40	49.55	49.81	50.05	50.39
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	27.90	16.97	22.11	135	121	35.11	31.88	43.63	22.74	27.86	39.96	26.33	15.46	71.89	27.86	39.96
Accounts Receivable	94.21	108	112	126	146	162	170	181	230	248	264	237	241	251	248	264
Other Current Assets	23.45	27.40	30.79	40.77	97.74	87.40	90.63	70.98	84.15	83.11	90.85	98.22	83.84	80.41	83.11	90.85
Total Current Assets	146	152	165	302	364	285	293	296	337	359	395	361	340	403	359	395

Property, Plant and Equipment	27.19	26.62	27.86	29.94	31.16	38.81	43.27	42.77	60.53	59.74	60.28	59.57	59.87	59.21	59.74	60.28
Intangible Assets	527	589	680	777	870	1,128	1,270	1,601	1,747	2,264	2,165	1,771	1,808	1,940	2,264	2,165
Other Long Term Assets	17.42	21.16	27.83	26.15	37.16	45.21	83.28	97.54	128	67.38	173	133	139	131	67.38	173
Total Assets	718	789	900	1,135	1,303	1,497	1,689	2,038	2,273	2,750	2,793	2,325	2,347	2,533	2,750	2,793

Accounts Payable	112	129	165	207	243	317	346	321	254	268	191	173	197	245	268	191
Current Portion of Long-Term Debt	0.69	0.62	0.88	0.48	0.47	0.26	0.23	0.13	0.14	0.10	0.10	0.12	0.10	0.09	0.10	0.10
Other Current Liabilities	8.38	1.44	1.16	14.28	21.30	--	--	--	--	--	--	-0.00	--	--	--	--
Total Current Liabilities	121	131	167	221	265	317	347	321	254	268	191	173	197	245	268	191

Long-Term Debt	1.18	54.69	0.62	0.38	0.46	140	50.21	147	29.33	144	184	83.81	0.29	48.26	144	184
Other Long-Term Liabilities	22.99	32.11	41.20	47.68	78.41	74.76	102	123	258	302	312	271	279	291	302	312
Total Liabilities	145	218	209	269	344	532	499	590	542	715	687	527	477	584	715	687

Common Stock	0.28	0.23	0.24	0.49	0.48	0.46	--	0.48	0.49	0.50	0.50	0.49	0.50	0.50	0.50	0.50
Retained Earnings	290	200	250	349	402	409	585	788	1,006	1,247	1,302	1,054	1,115	1,181	1,247	1,302
Additional Paid-In Capital	432	371	457	516	557	555	604	659	725	788	803	743	755	768	788	803
Treasury Stock	-150	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Equity	572	571	692	866	959	965	1,190	1,447	1,731	2,035	2,106	1,798	1,870	1,949	2,035	2,106
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	84.33	98.28	89.04	124	143	169	176	203	218	241	248	48.35	60.54	65.91	66.10	55.37
Depreciation, Depletion and Amortization	8.41	9.35	9.92	9.47	10.56	13.21	16.72	21.95	25.29	30.82	32.85	7.11	7.69	7.93	8.09	9.14
Cash Flow from Others	25.30	16.12	63.47	43.34	35.24	-1.02	48.85	15.92	27.73	53.97	58.65	-87.58	48.92	60.87	31.76	-82.90
Cash Flow from Operations	118	124	162	177	189	181	241	241	271	326	339	-32.12	117	135	106	-18.39

Investment for Property, Plant & Equipement	-15.27	-7.06	-7.89	-12.87	-8.51	-15.68	-14.95	-12.11	-31.33	-14.50	-15.91	-2.92	-3.90	-3.13	-4.55	-4.34
Cash Flow from Acquisitions	-75.24	-64.85	-91.94	-91.84	-119	-206	-151	-339	-155	-441	-414	-28.10	-36.77	-137	-239	-1.30
Cash Flow from Investing	-90.52	-80.77	-105	-156	-90.79	-223	-163	-362	-191	-461	-447	-29.39	-45.61	-134	-251	-15.64

Net Issuance of Stock	-72.07	-116	1.42	29.92	-72.61	-188	17.96	22.53	31.36	28.81	24.74	9.26	4.54	5.02	9.98	5.19
Net Issuance of Debt	-0.75	52.44	-54.81	-0.91	-0.46	137	-89.82	96.24	-120	112	98.01	54.46	-83.54	47.97	93.59	40.00
Other Financing	--	--	0.00	8.07	8.64	4.13	5.77	2.03	0.47	-3.74	-3.34	1.58	-2.78	0.73	-3.27	1.97
Cash Flow from Financing	-72.82	-63.87	-53.39	37.08	-64.43	-46.97	-66.08	121	-88.10	138	119	65.30	-81.78	53.72	100	47.17

Net Change in Cash	-45.30	-20.89	4.18	58.40	33.30	-88.48	12.16	-0.25	-7.66	2.68	12.04	3.79	-10.24	53.98	-44.84	13.15

Free Cash Flow	103	117	155	164	180	166	226	228	240	311	324	-35.04	113	132	101	-22.72
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

MD Quarterly/Annuals Reports

MD: 10-Q - MEDNAX, INC. (0000893949) (Filer): (10-Q) - 2012-11-01
MD: 10-Q - MEDNAX, INC. (0000893949) (Filer): (10-Q) - 2012-05-03
MD: 10-K - MEDNAX, INC. (0000893949) (Filer): (10-K) - 2012-02-29
MD: 10-Q - MEDNAX, INC. (0000893949) (Filer): (10-Q) - 2011-08-02
MD: 10-K - MEDNAX, INC. (0000893949) (Filer): (10-K) - 2011-02-24

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

MD Quarterly/Annuals Reports